Zai Lab Ltd (ZLAB) stock
ZLABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30471% above fair value
$24.60−1.44 (-5.53%)
Close on Nov 13, 2026Market cap $3.82BP/E –Yield –
Zai Lab operating margin
Operating margin is operating income as a percentage of revenue.
Zai Lab's operating margin for the twelve months ending Sep 30, 2026 was -63.0%. For fiscal 2025 it was -49.9%, against -70.7% the year before. The highest annual figure on record is -49.9% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -49.9% | +20.8 |
| FY2024 | Dec 31, 2024 | -70.7% | +66.7 |
| FY2023 | Dec 31, 2023 | -137.4% | +50.6 |
| FY2022 | Dec 31, 2022 | -188.0% | +297.1 |
| FY2021 | Dec 31, 2021 | -485.1% | +131.3 |
| FY2020 | Dec 31, 2020 | -616.4% | +948.4 |
| FY2019 | Dec 31, 2019 | -1564.9% | +108332.8 |
| FY2018 | Dec 31, 2018 | -109897.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -58.2% | −16.1 |
| Q2 FY2026 | Jun 30, 2026 | -71.9% | −22.0 |
| Q1 FY2026 | Mar 31, 2026 | -69.7% | −16.8 |
| Q4 FY2025 | Dec 31, 2025 | -54.4% | +7.9 |
| Q3 FY2025 | Sep 30, 2025 | -42.1% | +24.3 |
| Q2 FY2025 | Jun 30, 2025 | -49.9% | +25.8 |
| Q1 FY2025 | Mar 31, 2025 | -52.9% | +27.8 |
| Q4 FY2024 | Dec 31, 2024 | -62.2% | +126.1 |
| Q3 FY2024 | Sep 30, 2024 | -66.4% | +54.4 |
| Q2 FY2024 | Jun 30, 2024 | -75.7% | +54.3 |
| Q1 FY2024 | Mar 31, 2024 | -80.7% | +30.0 |
| Q4 FY2023 | Dec 31, 2023 | -188.3% | −32.9 |
| Q3 FY2023 | Sep 30, 2023 | -120.7% | +102.8 |
| Q2 FY2023 | Jun 30, 2023 | -130.0% | +74.9 |
| Q1 FY2023 | Mar 31, 2023 | -110.7% | +60.0 |
| Q4 FY2022 | Dec 31, 2022 | -155.4% | +343.2 |
| Q3 FY2022 | Sep 30, 2022 | -223.5% | −30.4 |
| Q2 FY2022 | Jun 30, 2022 | -204.9% | +256.9 |
| Q1 FY2022 | Mar 31, 2022 | -170.7% | +958.9 |
| Q4 FY2021 | Dec 31, 2021 | -498.6% | +132.5 |
| Q3 FY2021 | Sep 30, 2021 | -193.0% | +327.5 |
| Q2 FY2021 | Jun 30, 2021 | -461.8% | +301.9 |
| Q1 FY2021 | Mar 31, 2021 | -1129.6% | −566.0 |
| Q4 FY2020 | Dec 31, 2020 | -631.1% | +489.4 |
| Q3 FY2020 | Sep 30, 2020 | -520.5% | +806.2 |
| Q2 FY2020 | Jun 30, 2020 | -763.7% | – |
| Q1 FY2020 | Mar 31, 2020 | -563.7% | – |
| Q4 FY2019 | Dec 31, 2019 | -1120.5% | – |
| Q3 FY2019 | Sep 30, 2019 | -1326.6% | – |
See a number that looks wrong?